AI underweights weigh on large-cap funds performance says Goldman
Cardinal Health Inc (NYSE:CAH), a prominent healthcare provider with a market capitalization of $35.56 billion, saw its Chief Legal and Compliance Officer Jessica L. Mayer sell a total of $5.6 million in company shares on August 19, 2025. The sales, executed in three separate transactions, occurred at weighted average prices ranging from $148.08 to $149.52, near the stock’s 52-week high of $168.44. According to InvestingPro analysis, the stock currently appears undervalued based on its Fair Value assessment.
According to a Form 4 filing with the Securities and Exchange Commission, Mayer sold 4,345 shares at a weighted average price of $148.08, for a total of $643,415. Additionally, 33,333 shares were sold at a weighted average price of $148.91, for a total of $4,963,574. The final transaction involved the sale of 400 shares at a weighted average price of $149.52, totaling $59,808. These transactions come as Cardinal Health maintains its 43-year streak of consecutive dividend payments, with analysts maintaining a bullish outlook on the stock.
On August 15, Mayer also acquired 9,358 shares of Cardinal Health as part of a restricted share unit grant, valued at $0. Additionally, 27,927 shares were disposed of at $150.22, totaling $4,195,193 to cover tax obligations related to vesting restricted share units and performance share units.
Following these transactions, Mayer directly owns 48,457 shares of Cardinal Health Inc.
In other recent news, Cardinal Health reported its fourth-quarter earnings for fiscal 2025, which showed mixed results. The company achieved an earnings per share of $2.08, slightly exceeding the expected $2.03. However, its revenue fell short of forecasts, coming in at $60.2 billion against the anticipated $60.92 billion. In addition to the earnings report, Cardinal Health has announced a quarterly dividend of $0.5107 per share, payable to shareholders of record as of October 1, 2025. The dividend will be distributed on October 15, 2025. Furthermore, Cardinal Health disclosed a $1 billion public offering of senior notes in two tranches, with $600 million due in 2030 and $400 million due in 2035. The underwriting agreement for this offering involves major financial firms, including Goldman Sachs, BofA Securities, and Wells Fargo (NYSE:WFC) Securities. These developments reflect Cardinal Health’s recent strategic financial activities and investor-related announcements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.